Black Diamond Therapeutics Inc（BDTX）價格預測BDTXBlack Diamond Therapeutics Inc

Alphio's BDTX stock price prediction model matches the current Black Diamond Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.69 (+1.62%). The 1-week path is $1.70 (+2.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Black Diamond Therapeutics Inc. (BDTX) is a good buy right now due to its current price of $1.75, which is significantly below the analyst price targets of $10 and $11, indicating substantial upside potential. The forward P/E ratio of 8.33 suggests that the stock is undervalued relative to its future earnings potential. However, the stock has faced volatility, evidenced by a recent RSI of 40.11, indicating it is nearing oversold territory, which could present a buying opportunity. The main risk is the recent performance, with a 1-year change of -51.66%, reflecting market skepticism about its clinical trial results and future profitability.

Black Diamond Therapeutics Inc (BDTX) last closed at $1.66, losing -12.63%. These facts feed the 1-day and 1-week BDTX price prediction above.